While APP/PS1 and 5xFAD models exhibit temporal differences in amyloid pathology, both recapitulate gut-brain axis dysregulation characteristic of AD progression and share phenotypes of cognitive decline and neuroinflammation (Upadhyay et al., 2024). This evidence concerns the gene APP and Alzheimer disease.